Turning cold into hot: combination of pembrolizumab with bevacizumab and oral metronomic cyclophosphamide increases immune cell migration into the tumor microenvironment in responding patients with recurrent ovarian cancer (090)
| Autor: | Gaulin, Nicole, Chilakapati, Shanmuga Reddy, Zsiros, Emese |
|---|---|
| Zdroj: | In Gynecologic Oncology August 2022 166 Supplement 1:S61-S61 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect